SVB Financial Group
- SEC CIK
- 0000719739
- Latest filing
- Nov 10, 2025
KLRS holding history
Kalaris Therapeutics, Inc. in every 13F filed by SVB Financial Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KLRS overviewAll 13F holders of KLRSFull Q3 2025 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −17,207−100.0% | Sold out | Holders |
| Q3 2023 | 17,207 | $37.0K | 0.1% | −8,604−33.3% | Reduced | Holders |
| Q2 2023 | 25,811 | $87.8K | 0.2% | −8,604−25.0% | Reduced | Holders |
| Q1 2023 | 34,415 | $135.6K | 0.3% | −8,604−20.0% | Reduced | Holders |
| Q4 2022 | 43,019 | $220.7K | 0.6% | – | No prior filing | Holders |